Home/Companies/CIK 0000704328
S
ISSUER//CIK 0000704328

SOMANETICS CORP

Exchange

Entity type

operating

Fiscal year end

Nov 30

Headquarters

MI

Research Summary

AI-assisted · Grounded in filings

Updated Nov 24, 2025

SOMANETICS CORP

Somanetics Corp., operating within the Electromedical & Electrotherapeutic Apparatus SIC backdrop, specializes in portable, non-invasive cerebral and somatic oximetry systems that deliver continuous regional oxygen saturation data during surgery and critical care, with core products tailored for cardiovascular surgeons, anesthesiologists, and perioperative teams in hospitals and surgical centers seeking better neuromonitoring clarity; the company also supports rehabilitation clinics with monitoring accessories. CIK 704328 remains the anchor for compliance, and the latest Form 10-Q filed in September 1999 reiterates the heavy regulatory oversight from the FDA and CMS reimbursement scrutiny that could materially affect product rollouts, pricing, and adoption, especially given the capital-intensive nature of clinical procurement and the need to prove long-term value in a cautious capital market. Investors should weigh those risks along with the company’s efforts to expand clinical training and integration with EMRs. View live SEC filings on Earnings Feed.